Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Peter J. Kuipers net worth and biography

Peter Kuipers Biography and Net Worth

CFO of Omnicell

Peter Kuipers joined Omnicell in August 2015. Mr. Kuipers had served as CFO at Quantcast Corporation, a world leader in applying the power of big data and analytics to digital audience measurement and advertising. Previously he served as Executive Vice President and CFO at The Weather Company (TWC), operating The Weather Channel, weather.com, wunderground.com and its professional services division WSI. Earlier, Mr. Kuipers served in senior financial leadership roles at Yahoo!, Altera Corporation, General Electric Company, and Akzo Nobel. He holds a Master’s Degree in Economics and Business Administration from the Maastricht University School of Business and Economics in the Netherlands.

What is Peter J. Kuipers' net worth?: The estimated net worth of Peter J. Kuipers is at least $1.67 million as of August 26th, 2022. Mr. Kuipers owns 61,326 shares of Omnicell stock worth more than $1,671,134 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Kuipers may own. Learn More about Peter J. Kuipers' net worth.
How do I contact Peter J. Kuipers?: The corporate mailing address for Mr. Kuipers and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Peter J. Kuipers' contact information.
Has Peter J. Kuipers been buying or selling shares of Omnicell?: Peter J. Kuipers has not been actively trading shares of Omnicell during the past quarter. Most recently, Peter J. Kuipers sold 15,500 shares of the business's stock in a transaction on Friday, August 26th. The shares were sold at an average price of $108.29, for a transaction totalling $1,678,495.00. Following the completion of the sale, the chief financial officer now directly owns 61,326 shares of the company's stock, valued at $6,640,992.54. Learn More on Peter J. Kuipers' trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, Omnicell insiders bought shares 1 times. They purchased a total of 4,000 shares worth more than $295,040.00. During the last year, insiders at the sold shares 1 times. They sold a total of 7,951 shares worth more than $581,536.14. The most recent insider tranaction occured on June, 9th when EVP Christine Marie Mellon sold 7,951 shares worth more than $581,536.14. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 6/9/2023.

Peter J. Kuipers Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/26/2022	Sell	15,500	$108.29	$1,678,495.00	61,326
8/22/2022	Sell	11,000	$105.93	$1,165,230.00	61,326
12/7/2021	Sell	8,517	$181.15	$1,542,854.55
8/6/2021	Sell	11,500	$157.88	$1,815,620.00	59,812
5/18/2021	Sell	2,395	$135.53	$324,594.35	71,849
2/14/2020	Sell	11,267	$89.79	$1,011,663.93	46,378
5/8/2019	Sell	13,000	$81.62	$1,061,060.00	55,829
3/12/2019	Sell	24,504	$83.97	$2,057,600.88	64,618
3/9/2019	Sell	1,044	$44.34	$46,290.96	56,873
12/18/2018	Sell	2,429	$64.18	$155,893.22	47,814
12/10/2018	Sell	5,574	$70.11	$390,793.14	51,542
9/10/2018	Sell	5,574	$68.87	$383,881.38	51,542
8/14/2018	Sell	10	$63.25	$632.50	51,552
7/16/2018	Sell	2,818	$53.06	$149,523.08	54,370
6/6/2018	Sell	9,144	$49.57	$453,268.08	56,970
5/11/2018	Sell	3,456	$47.62	$164,574.72	56,970
4/12/2018	Sell	724	$46.00	$33,304.00	56,970
12/18/2017	Sell	1,926	$51.69	$99,554.94	40,544
11/17/2017	Sell	4,724	$47.74	$225,523.76	40,544
10/2/2017	Sell	3,532	$50.96	$179,990.72	40,714
8/9/2017	Sell	18,054	$50.31	$908,296.74	44,236

Peter J. Kuipers Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $27.25

$26.27

$27.31

50 Day Range

MA: $27.72

$26.15

$29.24

2 Week Range

Now: $27.25

$25.69

$77.14

Volume

322,455 shs

Average Volume

547,005 shs

Market Capitalization

$1.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad